Tribunal fines drug firms £69m for excessive pricing after CMA investigation

News Competition Sanctions & Fines

Date: 20th Nov, 2024 Source: Competition and Markets Authority Country: United Kingdom Original Source

Brief

"On 20/11/2024, the Competition and Markets Authority issued an update regarding Tribunal fines drug firms £69m for excessive pricing after CMA investigation. The CAT found Pfizer and Flynn guilty of abusing their dominant positions by charging excessive prices for a life-saving epilepsy drug, phenytoin sodium capsules, between 2012 and 2016, imposing combined fines totaling £69 million."

This content is restricted.

Highlights content goes here...

This content is restricted.

Competition and Markets Authority

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Tribunal fines drug firms £69m for excessive pricing after CMA investigation

Brief

Competition and Markets Authority

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Tribunal fines drug firms £69m for excessive pricing after CMA investigation

Brief

Competition and Markets Authority

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.